Literature DB >> 7825002

Upper airway carriage by Haemophilus influenzae and Streptococcus pneumoniae in Australian aboriginal children hospitalised with acute lower respiratory infection.

M Gratten1, K Manning, J Dixon, F Morey, P Torzillo, J Hanna, J Erlich, V Asche, I Riley.   

Abstract

When nasopharyngeal secretions from 171 Australian Aboriginal children hospitalized with acute lower respiratory tract infections (ALRI) were cultured selectively for Streptococcus pneumoniae and Haemophilus influenzae, 136 (79.5%) and 151 (88.3%) children yielded 166 and 254 isolates of S. pneumoniae and H. influenzae, respectively. In colonized subjects multiple populations of S. pneumoniae (20% of carriage-positive patients) and H. influenzae (55%) were common. Pneumococci belonging to 27 types or groups were identified. H. influenzae serotype b colonized 16.4% of all children studied. More than one half of 152 children tested were excreting antibiotics at the time of admission to hospital. Significantly fewer children with serum antibiotic residues were colonized with S. pneumoniae than were antibiotic free children. Antibiotic usage had no measurable impact on the isolation rate of H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7825002

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  12 in total

1.  Comparison between nasal swabs and nasopharyngeal aspirates for, and effect of time in transit on, isolation of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Kylie S Carville; Jacinta M Bowman; Deborah Lehmann; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

2.  How valid is single-colony isolation for surveillance of Streptococcus pneumoniae carriage?

Authors:  B M Charalambous; Ndekya M Oriyo; S H Gillespie
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

3.  Bronchoscopic findings in children with non-cystic fibrosis chronic suppurative lung disease.

Authors:  A B Chang; N C Boyce; I B Masters; P J Torzillo; J P Masel
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

4.  Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies.

Authors:  K L O'Brien; M A Bronsdon; R Dagan; P Yagupsky; J Janco; J Elliott; C G Whitney; Y H Yang; L G Robinson; B Schwartz; G M Carlone
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Vaccination against colonizing bacteria with multiple serotypes.

Authors:  M Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia.

Authors:  M Gratten; P Torzillo; F Morey; J Dixon; J Erlich; J Hagger; J Henrichsen
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Quantitative validation of media for transportation and storage of Streptococcus pneumoniae.

Authors:  B M Charalambous; S L Batt; A C Peek; H Mwerinde; N Sam; S H Gillespie
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Survival of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis frozen in skim milk- tryptone-glucose-glycerol medium.

Authors:  Tarja Kaijalainen; Esa Ruokokoski; Pentti Ukkonen; Elja Herva
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 9.  Understanding the pneumococcus: transmission and evolution.

Authors:  Eric S Donkor
Journal:  Front Cell Infect Microbiol       Date:  2013-03-07       Impact factor: 5.293

10.  Invasive disease due to Haemophilus influenzae type A in children in Canada's north: A priority for prevention.

Authors:  Andrée-Anne Boisvert; Dorothy Moore
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.